+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Organ-on-chip Market Report by Offering, Type, Application, End Use, and Region 2024-2032

  • PDF Icon

    Report

  • 139 Pages
  • July 2024
  • Region: Global
  • IMARC Group
  • ID: 5615305
The global organ-on-chip market size reached US$ 61.6 Million in 2023. Looking forward, the publisher expects the market to reach US$ 541.8 Million by 2032, exhibiting a growth rate (CAGR) of 27.3% during 2023-2032. The market is driven by its critical role in enhancing pharmaceutical R&D, stimulated by technological advancements, collaborative efforts, and increasing regulatory and ethical emphasis on reducing animal testing through more accurate and humane alternatives in medical research.

Organ-on-chip Market Analysis:

Major Market Drivers: The organ-on-chip market is expanding rapidly, driven by the need for more accurate and ethical research methods in pharmaceuticals and biotechnology.

Key Market Trends: Technological advancements such as 3D bioprinting and microfluidics are revolutionizing organ-on-chip models, increasing their accuracy and applicability.

Geographical Trends: North America leads the market, supported by robust research infrastructure and proactive regulatory policies; however, Europe and Asia-Pacific are quickly catching up due to rising investments in biotech.

Competitive Landscape: Some of the major market players in the organ-on-chip industry include Allevi Inc., Altis Biosystems, AxoSim, BiomimX S.r.l., Elveflow, Emulate Inc., InSphero, MIMETAS, Nortis Inc., TARA Biosystems Inc., TissUse GmbH., etc. among many others.

Challenges and Opportunities: While technological complexities and high costs pose challenges, the growing shift towards personalized medicine and the expansion into multi-organ models present significant organ-on-chip market opportunities.

Organ-on-chip Market Trends:

Pharmaceutical Research and Development Enhancement

The organ-on-chip market potential is greatly increased because it can dramatically enhance drug development and discovery. These techniques provide a more precise simulation of how human organs respond compared to conventional 2D cell cultures, and animal models and hence they help to reduce the time taken in drug testing and development. This innovation, thus, offers unparalleled prediction accuracy, essential for decreasing the duration, cost, and failure rates during drug discovery. As a result, pharmaceutical organizations are starting to integrate organ-on-chip technologies into their R&D processes to narrow the gap, leading to the advancement of personalized and precise medicine and higher therapeutic success rates. Besides, this shift produces the prospect of many quick drug approvals which partly cover the cost of those that failed in the final stage.

Technological Innovations and Collaborations

Continuous technological advancements are one of the major stimuli that are transforming the organ-on-chip industry. The manufacturing of chips capable of replicating several organ systems' functionalities at the same time is a more complete analysis tool, covering the first stage of preclinical testing and bringing clinical trials closer to the population. The inventions being made include incorporating microfluidics, 3D printing of cells within multi-dimensional structures, and automated imaging which allows for better functionality and scalability of organ-on-chip systems. Furthermore, associations between biotech firms, research institutions, and technology specialists have formed a strategic environment for cross-disciplinary studies that, in turn, results in fast improvements in this field. These collaborations are vital to overcoming technical issues and improving applications, as well as promoting various sectors like toxic things testing, disease modeling, and precision medicine. For instance, Organ-on-chip (OOC) technology revolutionizes traditional in vitro ADME and toxicity tests by offering a more accurate predictive model, enhancing drug development with an estimated growth rate of 15% annually. Incorporating multi-organ systems, OOC platforms enhance pharmacokinetic and pharmacodynamic studies, providing insights into the time and dose-dependent effects of drug molecules. Based on organ-on chip market revenue, these advanced technology, projected to reach a market size of $220 million by 2025, outperforms conventional 2D cultures with its precise flow control and rapid sample processing, making it essential for efficacy studies and toxicity evaluations.

Regulatory and Ethical Shifts

Ethical issues and stricter regulations concerning the application of animals in scientific research are additionally stimulating the growth of the organ-on-chip industry. Agencies and departments all around the world are coming to recognize the value of these technologies in providing more relevant data than animal models. This is what is being promoted by endeavors such as the USFDA’s Organ-on-Chip program. Therefore, this transition is consistent with the growing public and governmental push for animal-friendly investigation techniques. Organ-on-chip technologies, not only qualifying for higher regulatory standards, are also ethically warranted, since they can promote a paradigm shift towards more human and scientifically advanced research techniques. This ethical standpoint is getting an increasing role in wider approval for organ-on-chip devices to be used in research and development.

Organ-on-chip Market Segmentation:

The report provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on offering, type, application, and end use.

Breakup by Offering:

Products
Services

The report has provided a detailed breakup and analysis of the market based on the offering. This includes products and services.

Breakup by Type:

Liver
Heart
Lung
Kidney
Others

Lung holds the largest share of the industry

A detailed breakup and analysis of the market based on the type have also been provided in the report. This includes the liver, heart, lung, kidney, and others. According to the report, lung accounted for the largest market share.

According to the organ-on-chip market trend, the lung-on-chip is the most expanded due to its high application in respiratory studies and drug discovery. This technology is suitable for modeling the complex structure and function of the human lung to provide a dynamic platform for respiratory diseases, drug response evaluation, and inhaled substances toxicity assessment. Its role in the process of speeding up the development of personalized therapies for different lung diseases, such as asthma and chronic obstructive pulmonary disorder (COPD), is truly emphasized. Lung-on-chip model leads to a more reliable and ethical replacement of animal testing, hence the assurance of drug efficacy and safety to the authorities, which is a prerequisite for successful market entry. This shifts drug discovery and biotechnology to the leadership role in this area, continuing and increasing the organ-on-chip market share.

Breakup by Application:

Physiological Model Development
Drug Discovery
Toxicology Research

Drug discovery represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the application. This includes physiological model development, drug discovery, and toxicology research. According to the report, drug discovery represented the largest segment.

As per the organ-on-chip market overview, drug discovery is the largest segment for all phases of drug development. This is because the segment has such a key transforming way of developing the processes of pharmaceutical products. Organ-on-chip systems can mimic human organs' responses under various conditions in a way that otherwise would be impossible, allowing scientists to do early screenings for a prospective drug. This ability of the computer successfully enables us to estimate how those drugs will be affected by the human tissues, which in turn creates a step in the right direction of the efficacy and safety test process. It therefore follows that the drug discovery time frame is greatly shortened, and the clinical trial costs and risk become lower. The broadening utilization of these technologies by a pharmaceutical company indicates a great opportunity in this area to make drug hunting faster but not only, less costly and in line with better regulatory requirements for safety and effectiveness.

Breakup by End Use:

Pharmaceutical and Biotechnology Companies
Academic and Research Institutes
Cosmetics Industry
Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end use have also been provided in the report. This includes pharmaceutical and biotechnology companies, academic and research institutes, cosmetics industry, and others. According to the report, pharmaceutical and biotechnology companies accounted for the largest market share.

The pharmaceutical and biotechnology companies account for the largest market share. This superiority is mainly caused by the increased usage of micro-organ models in the drug discovery and development phases of these industries. The organ-on-chip companies use technology to copy human body functions and its responses to a higher level than conventional methods which use animal experimenting and 2D cell cultures. Improved capacities to match human organ functions and interact in a laboratory setting provide better detection of drug efficacy and toxicity at an early stage of development. It not only improves the prospects of success in the clinical trials but also decreases the time and cost involved in the process of commercialization of a new drug. Being that pharmaceutical and biotechnology company are constantly in search of inventive ways that will accelerate the research and development process, the utilization of organ-on-chip technologies is anticipated to keep increasing, therefore making this segment the largest one in the market and creating a positive organ-on-chip market outlook.

Breakup by Region:

North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

North America leads the market, accounting for the largest organ-on-chip market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for organ-on-chip.

According to the organ-on-chip market report, the largest segment here is North America. This superiority comes from a strong research infrastructure, good funding of the biotechnology and pharmaceutical industry, and the exemplary support given to innovative healthcare solutions by the government and the private sector North American confident leadership in the market is further fortified by the existence of leading universities and research institutions that always drive the frontiers of the medical fieldwork with the Increasing organ-on-chip demand in technologies. Other than that, the area fosters an already existing regulatory framework that provides high adoption opportunities of cutting-edge tools for drug development and personalized medicine which include organ-on-chip. The dominance of these economic entities is what pushes other players to innovate the development and deployment of such technologies contribute to the regional prominence in the global market. This active and advanced veterinary system provides organ-on-chip market growth models which makes these models in use in medical research and pharmaceutical testing.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the organ-on-chip industry include:

Allevi Inc.

Altis Biosystems
AxoSim
BiomimX S.r.l.

Elveflow
Emulate Inc.

InSphero
MIMETAS
Nortis Inc.

TARA Biosystems Inc.

TissUse GmbH

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Major players in the organ-on-chip industry keep improving and broadening their technological arsenals by different means, including research and development, cooperation, and mergers and acquisitions. According to organ-on-chip recent developments businesses aim to develop more specific and versatile organ-on-chip models capable of simulating human physiology more precisely for drug testing and disease modeling. The pragmatic cooperation is responsible for the quick product commercialization of new technologies in addition to broadening the microfluidic systems' application scope in personalized medicine, safety pharmacology, and complex biological research, which consequently fortifies their market positions. According to the organ-on-chip market forecast, strategic collaborations with pharmaceutical companies, academic institutions, and technology providers are creating a positive outlook for the market.

Organ-on-chip Market News:

On March 7, 2023, Allevi, a pioneer in 3D bioprinting, adopted this transformative technology for its ability to accurately mimic human biological systems in animal-free research. Its expanding applications in drug discovery, regenerative and translational medicine, and preclinical research highlight the significant potential of this platform.

On January 23, 2024, CN Bio and Altis Biosystems partnered to create an advanced human Gut/Liver in vitro model for improved ADME studies, leveraging their organ-specific expertise for more accurate predictions. This next-generation Organ-on-a-Chip solution is available early through CN Bio’s Contract Research Services.

On October 24, 2023, AxoSim, Inc., a leader in biomimetic human drug discovery platforms for neurological diseases, has completed its acquisition of microBrain™ assets from Vyant Bio’s StemoniX subsidiary. This move enhances AxoSim's capabilities in advancing neurological research.

Key Questions Answered in This Report

1. What was the size of the global organ-on-chip market in 2023?
2. What is the expected growth rate of the global organ-on-chip market during 2024-2032?
3. What are the key factors driving the global organ-on-chip market?
4. What has been the impact of COVID-19 on the global organ-on-chip market?
5. What is the breakup of the global organ-on-chip market based on the type?
6. What is the breakup of the global organ-on-chip market based on the application?
7. What is the breakup of the global organ-on-chip market based on the end use?
8. What are the key regions in the global organ-on-chip market?
9. Who are the key players/companies in the global organ-on-chip market?

Table of Contents

1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Organ-on-chip Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Offering
6.1 Products
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
7 Market Breakup by Type
7.1 Liver
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Heart
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Lung
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Kidney
7.4.1 Market Trends
7.4.2 Market Forecast
7.5 Others
7.5.1 Market Trends
7.5.2 Market Forecast
8 Market Breakup by Application
8.1 Physiological Model Development
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Drug Discovery
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Toxicology Research
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by End Use
9.1 Pharmaceutical and Biotechnology Companies
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Academic and Research Institutes
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Cosmetics Industry
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by Region
10.1 North America
10.1.1 United States
10.1.1.1 Market Trends
10.1.1.2 Market Forecast
10.1.2 Canada
10.1.2.1 Market Trends
10.1.2.2 Market Forecast
10.2 Asia-Pacific
10.2.1 China
10.2.1.1 Market Trends
10.2.1.2 Market Forecast
10.2.2 Japan
10.2.2.1 Market Trends
10.2.2.2 Market Forecast
10.2.3 India
10.2.3.1 Market Trends
10.2.3.2 Market Forecast
10.2.4 South Korea
10.2.4.1 Market Trends
10.2.4.2 Market Forecast
10.2.5 Australia
10.2.5.1 Market Trends
10.2.5.2 Market Forecast
10.2.6 Indonesia
10.2.6.1 Market Trends
10.2.6.2 Market Forecast
10.2.7 Others
10.2.7.1 Market Trends
10.2.7.2 Market Forecast
10.3 Europe
10.3.1 Germany
10.3.1.1 Market Trends
10.3.1.2 Market Forecast
10.3.2 France
10.3.2.1 Market Trends
10.3.2.2 Market Forecast
10.3.3 United Kingdom
10.3.3.1 Market Trends
10.3.3.2 Market Forecast
10.3.4 Italy
10.3.4.1 Market Trends
10.3.4.2 Market Forecast
10.3.5 Spain
10.3.5.1 Market Trends
10.3.5.2 Market Forecast
10.3.6 Russia
10.3.6.1 Market Trends
10.3.6.2 Market Forecast
10.3.7 Others
10.3.7.1 Market Trends
10.3.7.2 Market Forecast
10.4 Latin America
10.4.1 Brazil
10.4.1.1 Market Trends
10.4.1.2 Market Forecast
10.4.2 Mexico
10.4.2.1 Market Trends
10.4.2.2 Market Forecast
10.4.3 Others
10.4.3.1 Market Trends
10.4.3.2 Market Forecast
10.5 Middle East and Africa
10.5.1 Market Trends
10.5.2 Market Breakup by Country
10.5.3 Market Forecast
11 SWOT Analysis
11.1 Overview
11.2 Strengths
11.3 Weaknesses
11.4 Opportunities
11.5 Threats
12 Value Chain Analysis
13 Porters Five Forces Analysis
13.1 Overview
13.2 Bargaining Power of Buyers
13.3 Bargaining Power of Suppliers
13.4 Degree of Competition
13.5 Threat of New Entrants
13.6 Threat of Substitutes
14 Price Analysis
15 Competitive Landscape
15.1 Market Structure
15.2 Key Players
15.3 Profiles of Key Players
15.3.1 Allevi Inc.
15.3.1.1 Company Overview
15.3.1.2 Product Portfolio
15.3.2 Altis Biosystems
15.3.2.1 Company Overview
15.3.2.2 Product Portfolio
15.3.3 AxoSim
15.3.3.1 Company Overview
15.3.3.2 Product Portfolio
15.3.4 BiomimX S.r.l.
15.3.4.1 Company Overview
15.3.4.2 Product Portfolio
15.3.5 Elveflow
15.3.5.1 Company Overview
15.3.5.2 Product Portfolio
15.3.6 Emulate Inc.
15.3.6.1 Company Overview
15.3.6.2 Product Portfolio
15.3.7 InSphero
15.3.7.1 Company Overview
15.3.7.2 Product Portfolio
15.3.8 MIMETAS
15.3.8.1 Company Overview
15.3.8.2 Product Portfolio
15.3.9 Nortis Inc.
15.3.9.1 Company Overview
15.3.9.2 Product Portfolio
15.3.10 TARA Biosystems Inc.
15.3.10.1 Company Overview
15.3.10.2 Product Portfolio
15.3.11 TissUse GmbH
15.3.11.1 Company Overview
15.3.11.2 Product Portfolio
List of Figures
Figure 1: Global: Organ-on-chip Market: Major Drivers and Challenges
Figure 2: Global: Organ-on-chip Market: Sales Value (in Million US$), 2018-2023
Figure 3: Global: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 4: Global: Organ-on-chip Market: Breakup by Offering (in %), 2023
Figure 5: Global: Organ-on-chip Market: Breakup by Type (in %), 2023
Figure 6: Global: Organ-on-chip Market: Breakup by Application (in %), 2023
Figure 7: Global: Organ-on-chip Market: Breakup by End Use (in %), 2023
Figure 8: Global: Organ-on-chip Market: Breakup by Region (in %), 2023
Figure 9: Global: Organ-on-chip (Products) Market: Sales Value (in Million US$), 2018 & 2023
Figure 10: Global: Organ-on-chip (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 11: Global: Organ-on-chip (Services) Market: Sales Value (in Million US$), 2018 & 2023
Figure 12: Global: Organ-on-chip (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 13: Global: Organ-on-chip (Liver) Market: Sales Value (in Million US$), 2018 & 2023
Figure 14: Global: Organ-on-chip (Liver) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 15: Global: Organ-on-chip (Heart) Market: Sales Value (in Million US$), 2018 & 2023
Figure 16: Global: Organ-on-chip (Heart) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 17: Global: Organ-on-chip (Lung) Market: Sales Value (in Million US$), 2018 & 2023
Figure 18: Global: Organ-on-chip (Lung) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 19: Global: Organ-on-chip (Kidney) Market: Sales Value (in Million US$), 2018 & 2023
Figure 20: Global: Organ-on-chip (Kidney) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 21: Global: Organ-on-chip (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
Figure 22: Global: Organ-on-chip (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 23: Global: Organ-on-chip (Physiological Model Development) Market: Sales Value (in Million US$), 2018 & 2023
Figure 24: Global: Organ-on-chip (Physiological Model Development) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 25: Global: Organ-on-chip (Drug Discovery) Market: Sales Value (in Million US$), 2018 & 2023
Figure 26: Global: Organ-on-chip (Drug Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 27: Global: Organ-on-chip (Toxicology Research) Market: Sales Value (in Million US$), 2018 & 2023
Figure 28: Global: Organ-on-chip (Toxicology Research) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 29: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 30: Global: Organ-on-chip (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 31: Global: Organ-on-chip (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 32: Global: Organ-on-chip (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 33: Global: Organ-on-chip (Cosmetics Industry) Market: Sales Value (in Million US$), 2018 & 2023
Figure 34: Global: Organ-on-chip (Cosmetics Industry) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 35: Global: Organ-on-chip (Other End Uses) Market: Sales Value (in Million US$), 2018 & 2023
Figure 36: Global: Organ-on-chip (Other End Uses) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 37: North America: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 38: North America: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 39: United States: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 40: United States: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 41: Canada: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 42: Canada: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 43: Asia-Pacific: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 44: Asia-Pacific: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 45: China: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 46: China: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 47: Japan: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 48: Japan: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 49: India: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 50: India: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 51: South Korea: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 52: South Korea: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 53: Australia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 54: Australia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 55: Indonesia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 56: Indonesia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 57: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 58: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 59: Europe: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 60: Europe: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 61: Germany: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 62: Germany: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 63: France: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 64: France: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 65: United Kingdom: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 66: United Kingdom: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 67: Italy: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 68: Italy: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 69: Spain: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 70: Spain: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 71: Russia: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 72: Russia: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 73: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 74: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 75: Latin America: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 76: Latin America: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 77: Brazil: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 78: Brazil: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Mexico: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 80: Mexico: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 81: Others: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 82: Others: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 83: Middle East and Africa: Organ-on-chip Market: Sales Value (in Million US$), 2018 & 2023
Figure 84: Middle East and Africa: Organ-on-chip Market: Breakup by Country (in %), 2023
Figure 85: Middle East and Africa: Organ-on-chip Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 86: Global: Organ-on-chip Industry: SWOT Analysis
Figure 87: Global: Organ-on-chip Industry: Value Chain Analysis
Figure 88: Global: Organ-on-chip Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Organ-on-chip Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Organ-on-chip Market Forecast: Breakup by Offering (in Million US$), 2024-2032
Table 3: Global: Organ-on-chip Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: Organ-on-chip Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 5: Global: Organ-on-chip Market Forecast: Breakup by End Use (in Million US$), 2024-2032
Table 6: Global: Organ-on-chip Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 7: Global: Organ-on-chip Market: Competitive Structure
Table 8: Global: Organ-on-chip Market: Key Players

Companies Mentioned

  • Allevi Inc.
  • Altis Biosystems
  • AxoSim
  • BiomimX S.r.l.
  • Elveflow
  • Emulate Inc.
  • InSphero
  • MIMETAS
  • Nortis Inc.
  • TARA Biosystems Inc.
  • TissUse GmbH.

Methodology

Loading
LOADING...

Table Information